Skip to main navigation Skip to search Skip to main content

CTU: First-in-Human, Phase 1 Study of AMT-116, an Anti-CD44v9 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors

  • Park, John (Primary Chief Investigator)
  • Contacos, Christine (Clinical Trial Unit Staff)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • Keshiya, Shikara (Clinical Trial Unit Staff)
  • Morrisroe, Emma (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)

Project: Research

Project Details

Description

Sponsored clinical trial where the CTRA has Schedule 7 clauses. Please refer to legal for review and approval of Schedule 7
Short titleAMT-116-01
AcronymAMT-116-01
StatusActive
Effective start/end date13/07/23 → 12/07/28